Part 2/10:
Matthew Cranston, the Australian correspondent for The Australian, provides insight into these issues. He highlights that the chairman of CSL, Australia's largest drug manufacturing company, has expressed that the White House's apprehensions regarding the Pharmaceutical Benefits Scheme (PBS) are not entirely unfounded. The PBS serves as a cornerstone of Australia's healthcare system, subsidizing medicines to make them affordable.